clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Hyperemesis Gravidarum D006939 2 associated lipids
Empyema, Pleural D016724 2 associated lipids
Mastoiditis D008417 2 associated lipids
Pityriasis Rosea D017515 3 associated lipids
Duodenogastric Reflux D004383 2 associated lipids
Tuberculosis, Multidrug-Resistant D018088 6 associated lipids
Scrub Typhus D012612 3 associated lipids
Tuberculosis, Avian D014379 2 associated lipids
Typhoid Fever D014435 2 associated lipids
Central Nervous System Protozoal Infections D020808 3 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
Zautner AE Adenotonsillar disease. 2012 Recent Pat Inflamm Allergy Drug Discov pmid:22452646
Bergamaschi A et al. Recent Advances in the Treatment of Helicobacter pylori Infection. 2007 Recent Pat Antiinfect Drug Discov pmid:18221177
Campo SM et al. Antibiotic treatment strategies for Helicobacter pylori infection. 2007 Recent Pat Antiinfect Drug Discov pmid:18221161
Leonard S et al. Application of liquid chromatography/ion trap mass spectrometry to the characterization of the related substances of clarithromycin. 2006 Rapid Commun. Mass Spectrom. pmid:16991103
Calza P et al. Identification of the unknown transformation products derived from clarithromycin and carbamazepine using liquid chromatography/high-resolution mass spectrometry. 2012 Rapid Commun. Mass Spectrom. pmid:22730089
Kim HS et al. Serial CT findings of Mycobacterium massiliense pulmonary disease compared with Mycobacterium abscessus disease after treatment with antibiotic therapy. 2012 Radiology pmid:22371609
Ozdemir A et al. Detection of Helicobacter pylori colonization in dental plaques and tongue scrapings of patients with chronic gastritis. 2001 Quintessence Int pmid:12066673
Lin YH and Liu TC Mycobacterium chelonae infection involving the auricle. 2012 QJM pmid:21908384
Browne G et al. A potential role for keratinocyte growth factor and clarithromycin in the treatment of paraquat overdose. 2010 QJM pmid:20154068
Harvey E and Varatharaj A Round pneumonia. 2014 QJM pmid:23708793
Lin CM et al. Is ionizing radiation a risk factor to diffuse panbronchiolitis? 2017 QJM pmid:28069906
Burch LH and Picher M E-NTPDases in human airways: Regulation and relevance for chronic lung diseases. 2006 Purinergic Signal. pmid:18404479
Hasegawa N et al. Concentrations of clarithromycin and active metabolite in the epithelial lining fluid of patients with Mycobacterium avium complex pulmonary disease. 2009 Pulm Pharmacol Ther pmid:19061965
Yamada K et al. Azithromycin inhibits MUC5AC induction via multidrug-resistant Acinetobacter baumannii in human airway epithelial cells. 2014 Pulm Pharmacol Ther pmid:24910464
Morinaga Y et al. Azithromycin, clarithromycin and telithromycin inhibit MUC5AC induction by Chlamydophila pneumoniae in airway epithelial cells. 2009 Pulm Pharmacol Ther pmid:19716898
Gao X et al. Macrolide antibiotics improve chemotactic and phagocytic capacity as well as reduce inflammation in sulfur mustard-exposed monocytes. 2010 Pulm Pharmacol Ther pmid:19895898
Liu CP et al. NO-releasing xanthine KMUP-1 bonded by simvastatin attenuates bleomycin-induced lung inflammation and delayed fibrosis. 2014 Pulm Pharmacol Ther pmid:23518214
Nakamura M et al. Clarithromycin ameliorates pulmonary inflammation induced by short term cigarette smoke exposure in mice. 2015 Pulm Pharmacol Ther pmid:26363279
Martynova AV et al. Emergence of Haemophilus influenzae Strains in the Nasopharynx of Children with Tuberculosis. 2011 Pulm Med pmid:21766017
Rafii R et al. Update on pharmaceutical and minimally invasive management strategies for chronic obstructive pulmonary disease. 2011 Pulm Med pmid:21660228
Figueiredo Bde C and Ibiapina Cda C The role of macrolides in noncystic fibrosis bronchiectasis. 2011 Pulm Med pmid:22292118
Warner A Clarithromycin--a precipitant for acute psychotic stress. 2000 Nov-Dec Psychosomatics pmid:11110120
Mermelstein HT Clarithromycin-induced delirium in a general hospital. 1998 Nov-Dec Psychosomatics pmid:9819955
Jiang F et al. The influences of CYP2D6 genotypes and drug interactions on the pharmacokinetics of venlafaxine: exploring predictive biomarkers for treatment outcomes. 2015 Psychopharmacology (Berl.) pmid:25510856
Härtig G et al. [Symptomatic psychosis in bland sinus thrombosis and antibiotic therapy]. 1999 Psychiatr Prax pmid:10457975
Mrozińska M [Legionellosis in three children--cases report]. 2005 Przegl Epidemiol pmid:16729426
Mach T and Zahradnik-Bilska J [Reinfection with Helicobacter pylori in patients with duodenal ulcer after successful eradication]. 1999 Prz. Lek. pmid:10575912
Hydzik P et al. [Drug-induced erythrodermia complicated by multiorgan failure--case report]. 2011 Prz. Lek. pmid:22010450
Trzebiatowska I et al. [Psychosis caused by the treatment with clarithromycin--a case report]. 2011 Prz. Lek. pmid:22010468
Zwolińska-Wcisło M and Palka M [Principles of managing Helicobacter pylori infections. Guidelines of the European Society of Gastroenterology in Primary Health Care]. 2000 Prz. Lek. pmid:11293204
Thorley JA et al. Mechanisms of viral entry: sneaking in the front door. 2010 Protoplasma pmid:20446005
Sato Y et al. Macrolide antibiotics promote the LPS-induced upregulation of prostaglandin E receptor EP2 and thus attenuate macrolide suppression of IL-6 production. 2007 Prostaglandins Leukot. Essent. Fatty Acids pmid:17324565
Miyazaki M et al. Macrolide antibiotics inhibit prostaglandin E2 synthesis and mRNA expression of prostaglandin synthetic enzymes in human leukocytes. 2003 Prostaglandins Leukot. Essent. Fatty Acids pmid:12907132
Björkholm B et al. Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori. 2001 Proc. Natl. Acad. Sci. U.S.A. pmid:11717398
Pfister P et al. 23S rRNA base pair 2057-2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A-->G. 2005 Proc. Natl. Acad. Sci. U.S.A. pmid:15795375
Fahey JW et al. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. 2002 Proc. Natl. Acad. Sci. U.S.A. pmid:12032331
Shmelev EI et al. [Clarythromycin in the treatment of exacerbations of chronic obstructive lung disease]. 2006 Probl Tuberk Bolezn Legk pmid:17002058
James GD et al. Use of long-term antibiotic treatment in COPD patients in the UK: a retrospective cohort study. 2013 Prim Care Respir J pmid:23839240
Kwan BY and Rabheru K Manic episode associated with clarithromycin in a patient with medically treated depression. 2012 Prim Care Companion CNS Disord pmid:22943025
Sellal A et al. [Maintenance treatment of cerebral toxoplasmosis in AIDS: role of clarithromycin-minocycline combination]. 1996 Presse Med pmid:8685115
Contios S et al. [Mycobacterium marinum tenosynovitis of the abductors]. 2005 Presse Med pmid:15962499
Saint-Marc T et al. [Mycobacterium avium intracellulare infections. Treatment with a clarithromycin-clofazimine combination. 18 cases]. 1993 Presse Med pmid:8121903
Couture G et al. [Second case of serum sickness-like reaction to claritrhomycin]. 2016 Presse Med pmid:27542759
Esvant H et al. [Primary prophylaxis of cerebral toxoplasmosis in AIDS with clarithromycin]. 1993 Presse Med pmid:8337221
de Masson A et al. Cavitary pulmonary disease in a patient treated with natalizumab. 2014 Presse Med pmid:24742610
Mégraud F [Helicobacter pylori: bacteriological aspects, diagnostic methods, and susceptibility to antibiotics]. 2008 Presse Med pmid:18261874
Songné B et al. [Buruli ulcer in Togo: 21 cases]. 2001 Presse Med pmid:11317927
Courillon-Mallet A [Treatment of Helicobacter pylori infection]. 2008 Presse Med pmid:18255253
Morlet-Barla N et al. [Severe hypoglycemia and recurrence caused by disopyramide-clarithromycin interaction]. 2000 Jul 8-15 Presse Med pmid:10938688
Olivier D [HIV: a guide on management of seropositive patients]. 2001 Presse Med pmid:11268903